Indivior (INDV)


INDV Share PerformanceMore

52 week high382.30 17/02/17
52 week low202.80 24/06/16
52 week change 103.70 (45.19%)
4 week volume33,452,465 29/05/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

RBP-6000 Investor Event

RNS Number: 2638I Indivior PLC 16 June 2017 Indivior to Host Investor Event on RBP-6000 on June 29that 12:00 Noon EDT US (5:00 P.M. UK Time) Slough, UK, and Richmond, VA, June 16th, 2017 - Indivior PLC (LON: INDV) today announced that it will host an investor presentation on RBP-6000, its once monthly injectable buprenorphine which is being developed ...

Block Listing Six Monthly Return

RNS Number: 9854G Indivior PLC 02 June 2017 BLOCK LISTING SIX MONTHLY RETURN Date: June 2, 2017 Name of applicant: INDIVIOR PLC Name of scheme: U.S. EMPLOYEE STOCK PURCHASE PLAN Period of return: From: DECEMBER 2, 2016 To: JUNE 1, 2017 Balance of unallotted securities under scheme(s) from previous return: 1,500,000 ORDINAR...

Total Voting Rights

RNS Number: 9092G Indivior PLC 01 June 2017 Indivior PLC - Total Voting Rights and Capital In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1, Indivior PLC (the 'Company') hereby notifies the market that as at June 1, 2017 the Company's issued share capital consisted of 720,988,383 O rdinary Shares of US$0.10 each. The Company does n...

RBP-6000 - Submission of NDA to U.S. FDA

RNS Number: 6059G Indivior PLC 30 May 2017 Indivior Submits New Drug Application to U.S. FDA for RBP-6000 Buprenorphine Monthly Depot A Potential Novel Long-Acting, Sustained-Release Product Candidate for Treatment of Opioid Use Disorder Slough, UK, 30 May 2017 - Indivior PLC (LON: INDV) (the 'Company') today announced that the Company has ...

Jefferies Global Healthcare Conference

RNS Number: 9881F Indivior PLC 23 May 2017 Indivior's Shaun Thaxter to present at the Jefferies Global Healthcare Conference on June 6th Slough, UK, May 23rd, 2017 - Indivior PLC (LON: INDV) today announced that Shaun Thaxter, CEO, will present at the Jefferies Global Healthcare Conference on June 6th, 2017, at 10:00 a.m. local time, in New York City. Mark...

Indivior resolutions passed at AGM

Indivior has confirmed that all resolutions proposed at its annual general meeting yesterday were passed on a poll. At 8:56am...

Result of AGM

RNS Number: 4750F Indivior PLC 17 May 2017 IndiviorPLC (the 'Company') Poll results of3 rd Annual General Meeting ('AGM') May17,2017 The Company announces that at its AGM, held onMay17,2017, all resolutions set out in the Notice of AGM were passed on a poll. Resolutions1 to 17were passed as Ordinary Resolutions and Resolutions 18 to 21 were passed as Specia...

Indivior Q1 profit, revenue up in Q1

Indivior has reported that operating profit for the first quarter of 2017 was $128m (Q1 2016: $101m) primarily reflecting low...

Latest discussion posts More

  • Takeover?

    The FT quotes: "If Indivior can navigate these legal risks while keeping market share steady, ?it could become a target for a larger peer,? RBC said in a recent note. RBC named ...
  • NEW ARTICLE: Don't write off reliable Reckitt Benckiser

    "With the fatal South Korean disinfectant scandal, tough Russian market and sluggish take-up of Scholl footwear products, LSE:RB.:Reckitt Benckiser missed City forecasts in the ...
    II Editor
  • Re: Time to bank profits?

    The Telegraph's Questor again showed his form in advising to sell these at #1.70 a couple of months ago, and now they are #3.42. The RB-6000 drug had good results in its ...

Users' HoldingsMore

Users who hold Indivior also hold..

Codes & Symbols